Both in Pharmaceuticals
Corcept Therapeutics vs Spyre Therapeutics
Over the past year CORT returned +10.5% and SYRE returned +317.5%; their daily moves had a correlation of 0.14.
CORT +10.5% SYRE +317.5%Growth of $1, one year, split-adjusted
| Metric | CORT | SYRE |
|---|---|---|
| Price | $81.93 | $99.27 |
| Market cap | $8.86B | $9.28B |
| Today | +1.83% | +3.94% |
| 1 month | −32.9% | +7.1% |
| 6 months | +59.6% | +39.8% |
| Year to date | +135.4% | +203.0% |
| 1 year | +11.5% | +305.8% |
| Revenue growth (YoY) | +31.7% | — |
| Gross margin | 98.4% | — |
| Net margin | 16.8% | — |
| P/E (TTM) | 162.5× | — |
| Price / sales | 10.7× | — |
| Net cash | $308.2M | $1.15B |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 59.2% |
| Short % of float | 9.0% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).